Assignments got your hair on fire?

Douse the flames with our full-range writing service!

Experienced academic writing professionals are at your fingertips. Use this handy tool to get a price estimate for your project.

Immunotherapies for Aggressive Prostate Cancer

Sadly, cervical cancer used to be the common cause of cancer deaths in women, but fatalities greatly reduced since the development of the Pap smear in the 1930s (American Cancer...).

Would you say your chances of getting cancer is…” The responses were: very low (1,130); somewhat low (1,729); moderate (2,872); somewhat high (995); very high (353); refused (27); and don’t know (217)....

Prostate cancer ranges from grade one to grade ten, with ten being the most advanced.

Prostate Cancer Treatment Jacksonville, Florida

The PSA test has been approved for use since 1994 to detect early prostate cancer....

Maahum Haider, Paul H. Lange. . 2016. Breast and Prostate Cancers: A Comparison of Two Endocrinologic Malignancies. Prostate Cancer, 157-165.

Barbara K. Dunn, Ellen Richmond, Darrell E. Anderson, Peter Greenwald. . 2016. Testing the Ability of Selenium and Vitamin E to Prevent Prostate Cancer in a Large Randomized Phase III Clinical Trial. Molecular Basis of Nutrition and Aging, 567-582.

Non-PSA Blood Test for Prostate Cancer Risk Assessment

The strongest evidence of benefit for PSA screening for early diagnosis of prostate cancer is in the age group 55 to 69 years17 since this is the group studied in randomized trials. Thus, targeting of men age 55 to 69 years, after a risk benefit discussion, represents one approach to screening that is based on best evidence.

Most women are in the menopausal phase of life when this cancer occurs.

Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.

Versatile Services that Make Studying Easy
We write effective, thought-provoking essays from scratch
We create erudite academic research papers
We champion seasoned experts for dissertations
We make it our business to construct successful business papers
What if the quality isn’t so great?
Our writers are sourced from experts, and complete an obstacle course of testing to join our brigade. Ours is a top service in the English-speaking world.
How do I know the professor won’t find out?
Everything is confidential. So you know your student paper is wholly yours, we use CopyScape and WriteCheck to guarantee originality (never TurnItIn, which professors patrol).
What if it doesn’t meet my expectations?
Unchanged instructions afford you 10 days to request edits after our agreed due date. With 94% satisfaction, we work until your hair is comfortably cool.
Clients enjoy the breezy experience of working with us
Click to learn our proven method

URF - The Site for Prostate Cancer Information

term paper on Prostate Cancer. - Planet Papers

The median age at the time of prostate-cancer diagnosis was 70 years in the two study groups. Among men in whom prostate cancer had been diagnosed, the hazard ratio for death in the finasteride group was 1.01 (95% CI, 0.85 to 1.20; P=0.90); after adjustment for cancer grade, age at diagnosis, race, and a family history of prostate cancer, the hazard ratio was 0.93 (95% CI, 0.78 to 1.12; P=0.45) (). At 10 years, the rate of survival among patients with any grade of prostate cancer was 79.3% in the finasteride group and 79.5% in the placebo group. When men were classified according to cancer grade, the 10-year survival rates were 83.0% in the finasteride group and 80.9% in the placebo group among those with low-grade prostate cancer and 73.0% and 73.6%, respectively, among those with high-grade prostate cancer ().

Prostate Cancer Essay - 87,000+ Free Term Papers and …

At the time of randomization (1994 to 1997), the median age of participants was 63.2 years. As of October 31, 2011, among the men who were still alive, the median age was 78.7 years. after adjustment for age, race, and a diagnosis of prostate cancer, the hazard ratio was 1.03 (95% CI, 0.98 to 1.09; P=0.26).

PROSTATE CANCER. - Academic Term Papers

When the results were limited to the subgroup of men in whom prostate cancer was diagnosed at the time of the original report, the results were unchanged. The test for interaction between treatment and cancer grade was not significant (P=0.32), indicating that the between-group difference in the risk of death from high-grade disease was not significant. The rate of prostate-cancer–specific survival could not be calculated because of the small number of men for whom the cause of death was ascertained.

Term Paper On Prostate Cancer - …

Although early detection of prostate cancer by means of PSA testing may lead to reduced mortality from the disease, it also leads to a substantial overdetection of cancer, most notably the diagnosis of low-grade tumors. Despite the evidence from one randomized clinical trial showing a significant reduction in the risk of death from prostate cancer with PSA testing, the risk of overdetection contributed greatly to the recommendation of the U.S. Preventive Services Task Force against PSA testing.

matter prostate cancer term papers | Best Service

Extrapolating results from one population to another must be done cautiously since the benefits of screening are dependent on the baseline incidence of and mortality from cancer without screening, the specific screening protocol, biopsy referral criteria and compliance with biopsy recommendations. The mortality from prostate cancer in the absence of screening is higher in the Netherlands and Sweden as compared to the US13 and these were the only two countries of the seven participating in the ERSPC trial where a mortality benefit was observed. Thus, the benefits of PSA-based screening seen in these two countries may not be generalizable to the US population. Further, the screening protocol, criteria for biopsy referral and compliance with biopsy recommendations differed considerably in the US population and ERSPC trial settings.

Prostate cancer nutrition research papers

In the original PCPT, there was a relative reduction of 38% in the risk of prostate cancer with a Gleason score of 2 to 6 (). A major lingering concern, despite the evidence of enhanced cancer detection in men receiving finasteride, was the observed absolute increase in the number of high-grade cancers that were diagnosed. In 2011, the Food and Drug Administration mandated revisions to the labels for 5α-reductase inhibitors stating that the drugs may increase the risk of high-grade prostate cancer and are not approved for the prevention of prostate cancer. Specifically, there was concern that the high-grade cancers detected among men receiving finasteride would be clinically more aggressive and thus more lethal. If the increase in high-grade prostate cancers was not a finasteride-driven artifact of detection but rather reflected new high-grade cancers induced by finasteride, some increase in mortality among men receiving finasteride should become obvious during long-term follow-up.

of clients claim significantly improved grades thanks to our work.
of students agree they have more time for other things thanks to us.
Clients Speak
“I didn’t expect I’d be thanking you for actually improving my own writing, but I am. You’re like a second professor!”